Molecular Diagnostics Market : By Technology (Polymerase chain reaction, Microarray, Next-generation sequencing, Isothermal nucleic acid amplification, Hybridization, Others), By Application (Caner, Blood screening, Infectious diseases, Microbiology, Genetic tests, Others), BY End User (Hospitals, Diagnostic Centres, Research institutes, Others), and Geography


Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Molecular Diagnostics Market size was valued at USD 9,682.4 million in 2021, growing at a CAGR of 10.1% from 2022 to 2028. The global market provides a detailed overview and that can be segmented by technology, by application, and by end user. By technology, the global molecular diagnostics market has been segmented into Polymerase chain reaction, Microarray, Next-generation sequencing, Isothermal nucleic acid amplification, Hybridization, and Others. The Polymerase chain reaction segment is likely to be the largest and fastest-growing segment in terms of type in 2021 and is expected to maintain the trend in the forecasted years.  This is attributed to the detection of infectious diseases such as COVID-19 and others. The growing prevalence of infectious diseases are boosting the global market growth at a significant rate. The high demand for high throughput PCR test to detect infectious diseases are increasing the popularity of the PCR kits and reagents in the global market. Next-generation sequencing is also very popular technology in molecular diagnostic market which will further drive the global market growth at a significant rate. Based on application, the global molecular diagnostics market is segmented into Cancer, Blood screening, Infectious diseases, Microbiology, Genetic tests, Others. Among these, the Infectious diseases segment is expected to have the fastest-growing market during the forecast period 2022-2028 according to precision business insights. It is due to the increasing prevalence of infectious diseases across the world. Based on end user, the global molecular diagnostics market is segmented into Hospitals, Diagnostic Centres, Research institutes, Others. The Diagnostic Centres segment accounts for the largest share in 2021 and is anticipated to register a significant CAGR in the upcoming years.   Key Development: In Oct 2022, Roche launched its next-generation portfolio of SARS-CoV-2 rapid antigen tests (“2.0”) under CE Mark for self-test and professional use. In Sept 2022, Eurofins Genoma announced their launch of niPGT-A, a non-invasive, embryo biopsy free, preimplantation genetic aneuploidy screening test.

Global Molecular Diagnostics Market Summary

Study Period


Base Year




Largest Market


Fastest Growing Market

North America
Molecular Diagnostics Market Dynamics

Increase in the prevalence of infectious diseases and various cancers, a rise in demand for personalized medicines, technological advancements in the diagnostic tests, and rise in the preference for biomarker identification tests are anticipated to propel the market growth over the forecast years.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Molecular Diagnostics Market Segmentation

By Product Type
  • Reagents
  • Kits
  • Instruments
  • Software
By Technology
  • Polymerase chain reaction
  • Microarray
  • Next-generation sequencing
  • Isothermal nucleic acid amplification
  • Hybridization
  • Others
By Application
  • Caner
  • Blood screening
  • Infectious diseases
  • Microbiology
  • Genetic tests
  • Others
By End User
  • Hospitals
  • Diagnostic Centres
  • Research institutes
  • Others

Frequently Asked Questions

The fastest-growing segment of the global molecular diagnostics market is PCR technology due to its accuracy, less time consuming and ability to give real time data.

Introduction of alternative technologies are the key challenges to sustain in the global molecular diagnostics market.

Emerging countries like India, Brazil etc has enormous opportunities in this market. It expected to offer potential growth in the market due to untapped region.

New product launches and acquisitions, collaborations are recent trends in the global market to grow at a faster rate.

[urltag url='request-table-of-content']

  • Danaher Corporation (U.S)
  • Biomerieux (Sofiana s.a.) (France)
  • Beckman Coulter, Inc. (U.S.)
  • Becton, Dickinson and Company (U.S.)
  • Siemens Healthcare GmbH (Germany)
  • Abbott Laboratories (U.S.)
  • Grifols (Spain)
  • Hologic, Inc. (U.S.)
  • Qiagen (U.S.)
  • Alere Inc. (U.S.)
  • Roche Diagnostics (U.S.)
  • DiaSorin S.p.A. (American Standard Companies) (Italy)